Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Simon Mendelsohn (cohort 2015-16) co-authored this article.

We evaluated longitudinal kinetics of an 11-gene blood transcriptomic tuberculosis (TB) signature, RISK11, and effects of TB preventative therapy (TPT) and respiratory organisms on RISK11 signature score, in HIV-uninfected and HIV-infected individuals. Methods RISK11 was measured in a longitudinal study of RISK11-guided TPT in HIV-uninfected adults, a cross-sectional respiratory organisms cohort or a longitudinal study in people living with HIV (PLHIV). HIV-uninfected RISK11+ participants were randomised to TPT or no TPT; RISK11- participants received no TPT. PLHIV received standard-of-care ART and TPT. In the cross-sectional respiratory organisms cohort, viruses and bacteria in nasopharyngeal and oropharyngeal swabs were quantified by RT-qPCR. Measurements and Main Results RISK11+ status was transient in most of the 128 HIV-negative participants with longitudinal samples; >70% of RISK11+ participants reverted to RISK11- by 3 months, irrespective of TPT. By comparison, reversion from a RISK11-positive state was less common in 645 PLHIV (42.1%). Non-HIV viral and non-tuberculous bacterial organisms were detected in 7.2% and 38.9% of the 1,000 respiratory organisms cohort participants, respectively, and among those investigated for TB, 3.8% had prevalent disease. Median RISK11 scores (%) were higher in participants with viral organisms alone (46.7%), viral and bacterial organisms (42.8%), or prevalent TB (85.7%), than those with bacterial organisms other than TB (13.4%), or no organisms (14.2%). RISK11 could not discriminate between prevalent TB and viral organisms. Conclusions Positive RISK11 signature status is often transient, possibly due to intercurrent viral infection, highlighting potentially important challenges for implementation of these biomarkers as new tools for TB control. This article is open access and distributed under the terms of the Creative Commons Attribution 4.0 International License (


Visit the American Journal of Respiratory and Critical Care Medicine to read the full article.

Similar stories

International Day of Women and Girls in Science 2023

For this year’s International Day of Women and Girls in Science on 11 February, we asked a few of the IHTM teaching team to reflect on their science careers and in particular their experience of working in global health.

IHTM 2023 Oxford Union Debate – Climate Change

The IHTM Oxford Union Debate has been a key fixture in the course’s calendar for many years. This year's debate on climate change proved lively and engaging.

Honing Negotiation Skills with CPDS

Following mock exams, Hilary term got fully underway with a one-day workshop on International Negotiation Skills run by the Centre for Political & Diplomatic Studies, CPDS. The aim was to explore the principles of effective negotiation and engagement, evaluating the different styles of negotiation and examining the dynamics and skills of influencing.

All-Innovate Ideas Competition

Congratulations to Quyen Tran, IHTM 2022, who reached the Quarter Finals of the 2022 All-Innovate Ideas Competition run by the University of Oxford. The competition aims to encourage students to develop an entrepreneurial skill set and generate entrepreneurial ideas.

Professor Proochista Ariana elected to University Council

The IHTM family and friends would like to congratulate IHTM Course Director, Professor Proochista Ariana who has been elected to University Council.

Ethics and Governance PBL

IHTM students spent last week studying ethics and governance in public health programming (PHP) and global health research (GHR).